Komori
Pharma Foods International (2929) · PolicyRestated

Emphasis on Cash Flow and Maintenance of a Stable Financial Base

First written in FY2019. 8 of 9 entries say "Restated". Latest entry: FY2024-Q2.

9entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2024-Q22019: 120192020: 120202021: 320212022: 220222023: 120232024: 12024
Same theme, other companies
Stabilizing Liquidity Through Maturity-Based Working Capital FundingA theme 109 companies write about · 0 as a headwind · 106 as a tailwind

59 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 109 companies compared. The sentences above are computed from all 109.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q2RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has reaffirmed its financing policy of combining internal funds with borrowings from financial institutions, primarily using short-term borrowings for working capital and long-term borrowings for capital expenditures.
  2. FY2024-Q1RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its financing policy of primarily using internal funds and short-term borrowings for working capital, and long-term borrowings for capital expenditures.
  3. FY2022-Q3RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its financing policy of combining internal funds with borrowings from financial institutions, primarily using short-term borrowings for working capital and long-term borrowings for capital expenditures.
  4. FY2022-Q2RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its policy of financing working capital and capital expenditures through internal funds and borrowings from financial institutions.
  5. FY2022-Q1RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its financing policy of primarily using internal funds and short-term borrowings for working capital, and long-term borrowings for capital expenditures.
  6. FY2021-Q3RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its policy of financing working capital and capital expenditures through internal funds and borrowings from financial institutions.
  7. FY2021-Q2RestatedAnnual report

    「The group's working capital and capital expenditures are financed with internal funds and borrowings from financial institutions. Working capital is financed primarily with internal funds and short-term borrowings, while capital expenditures are financed primarily with long-term borrowings.」

    The company has continued its financing policy of primarily using internal funds and short-term borrowings for working capital, and long-term borrowings for capital expenditures.
  8. FY2020-Q2RestatedAnnual report

    「The group finances its working capital and capital expenditure through internal funds and borrowings from financial institutions.」

    The company has continued its policy of financing working capital and capital expenditures through internal funds and borrowings from financial institutions.
  9. FY2019First statedAnnual report

    「We will manage the business with an emphasis on cash flow and make appropriate investment decisions while maintaining a sound financial base.」

    The company has indicated a policy of making investment decisions while emphasizing cash flow and maintaining a sound financial base, alongside improving profitability as the business expands.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Pharma Foods International yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Emphasis on Cash Flow and Maintenance of a Stable Financial Base | Pharma Foods International Co.,Ltd. (2929) | Komori